As the US struggles with skyrocketing rates of anxiety and depression, electronic health-record startup Osmind helps healthcare providers manage their patients, run their practices, and allows everyone to contribute to research for better treatments in the future. Using EHRs for research isn’t a new concept, with Flatiron Health and Verily using EHR data to gain insights into drug and therapy options for diseases ranging from cancer to heart disease. But Osmind is leading the race to bring this concept to the area of mental health, building a dataset of patient’s real-time reported symptoms that can be analyzed by researchers studying drugs or other interventions. The company is partnered with Stanford University School of Medicine, United BioSource, insurance company Enthea and mental health platform First Tracks. Following a substantial $40 million funding raise in 2023, it has been focusing on critical product improvements and hiring new talent.